General MedicationsORALGeneric
ERYTHROMYCIN ETHYLSUCCINATE
ERYTHROMYCIN ETHYLSUCCINATE
Standard Dose
EQ 200MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview ERYTHROMYCIN ETHYLSUCCINATE is listed in Drugs@FDA under application 062559 (ANDA).
Marketing status: Discontinued Active ingredient ERYTHROMYCIN ETHYLSUCCINATE Form and strength SUSPENSION;ORAL - EQ 200MG BASE/5ML Sponsor PHARMAFAIR Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview ERYTHROMYCIN ETHYLSUCCINATE is listed in Drugs@FDA under application 062559 (ANDA). Marketing status: Discontinued Active ingredient ERYTHROMYCIN ETHYLSUCCINATE Form and strength SUSPENSION;ORAL - EQ 200MG BASE/5ML Sponsor PHARMAFAIR Submission history See approval history documents.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.